Skip to main content
OpenTrials
Completed

NCT Number: NCT06955104

Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia

A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients with Dyslipidemia

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Asan Medical Center

Seoul, 05505, South Korea

About this study

To evaluate the efficacy and safety of JW0108+C2407 in dyslipidemia patients

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age of 19 years old at the time of written informed consent
  • Patients with dyslipidemia

Exclusion criteria

  • Secondary dyslipidemia
  • Patient who does not meet the specified TG, LDL-C level

Treatment and study plan

JW0108 + C2407

Drug

JW0108 + C2407

JW0108 + C2407 placebo

Drug

JW0108 + C2407 placebo

Primary outcomes

  1. Percent change from baseline in LDL-C

    Time frame: Week 8

    Check LDL-C

Secondary outcomes

  1. Efficacy and Safety: Change from baseline in LDL-C (mg/dL)

    Time frame: Week 8

    Check LDL-C

Sponsors and collaborators

Lead sponsor

JW Pharmaceutical

Industry

Registry information

Official study title

A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
May 2, 2025
Registry last updated
Sep 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.